VEGF receptors are differentially expressed by neuroblastoma cells in culture

Journal of Pediatric Surgery

Volumn 38, Issue 3, 2003, Pages 514-521

  Beierle, Elizabeth A ^a,b   Dai, Wei ^a   Langham Jr , Max R ^a   Copeland III, Edward M ^a   Chen, Mike K ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Flt 1; Flt 4; IMR 32; KDR flk 1; Neuroblastoma; Neuropilin 1; Neuropilin 2; Serum starvation; Tumor necrosis factor alpha; Vascular endothelial growth factor; VEGF receptors

Indexed keywords

CYTOKINE; NEUROPILIN 1; NEUROPILIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 3;

APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MITOGENESIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037370288     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2003.50091     Document Type: Conference Paper

References (59)

1. Evans A, Gerson J, Schnaufer L: Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44:49-54, 1976
2. Haas D, Ablin AR, Miller C, et al: Complete pathologic maturation and regression of Stage IVS neuroblastoma without treatment. Cancer 62:818-825, 1988
3. Borgstrom P, Hillan KJ, Sriramarao P, et al: Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibodies. Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56:4032-4039, 1996
4. Prewett M, Huber J, Li Y, et al: Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59:5209-5218, 1999
5. Yoshiji H, Gomez DE, Shibuya M, et al: Expression of vascular endothelial growth factor, its receptors, and other angiogenic factors in breast cancer. Cancer Res 56:2013-2016, 1996
6. Brown LF, Berse B, Jackman RW, et al: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735, 1993
7. Suzuki K, Hayashi N, Miyamoto Y, et al: Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56:3004-3009, 1996
8. Meister B, Grunebach F, Bautz F, et al: Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer 35:445-449, 1999
9. Beierle EA, Strande LF, Chen MK: VEGF is upregulated in a neuroblastoma and hepatocyte co-culture model. J Surg Res 97:34-40, 2001
10. Beierle EA, Strand LF, Chen MK: VEGF upregulates Bcl-2 expression and is associated with deceased apoptosis in neuroblastoma cells. J Pediatr Surg 37:467-471, 2002
11. Latil A, Bieche I, Pesche S, et al: VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 89:167-171, 2000
12. Thierry A, Kotelevets L, Vaillant JC, et al: VEGF, VEGF-B, VEGF-C, and their receptors KDR, Flt-1 and Flt-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86:174-181, 2000
13. Carmeliet P, Ferreira V. Breier G. et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439, 1996
14. Folkman J, Klagsbrun M: Angiogenic factors. Science 235:442-447, 1987
15. Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82:4-6. 1991
16. Ferrara N. Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18:4-25, 1997
17. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931- 10934, 1992
18. Mattern J, Koomagi R, Volm M: Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73:931-934, 1996
19. Brown LF, Berse B. Jackman RW. et al: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86-91, 1995
20. Rossler J, Briet S, Havers W, et al: Vasculare endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia Int J Cancer 81:113-117. 1999
21. Eggert A, Ikegaki N, Kwiatkowski J. et al: High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6:1900-1908, 2000
22. Meitar D, Crawford SE, Rademaker AW, et al: Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Onc 14:405-414, 1996
23. Seetharam L, Gotoh N, Maru Y, et al: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor (VEGF). Oncogene 10: 135-147. 1995
24. Waltenberger J, Claessonwelsh L, Siegbahn A, et al: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995, 1994
25. Gille H, Kowalski J, Li B, et al: Analysis of biological effect and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 276:3222-3230, 2001
26. Barleon B, Sozzani S, Zhou D. et al: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343, 1996
27. Jussila L, Valtola R, Partanen TA, et al: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58:1599-1604, 1998
28. Dumont DJ, Jussila L, Taipale J, et al: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949, 1998
29. Neufeld G. Cohen T, Gengrinovitch S. et al: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22, 1999
30. Gluzman-Poltorak Z. Cohen T, Herzog Y, et al: Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 275:18040-18045, 2000
31. Kitsukawa T, Shimizu, M, Sanbo M. et al: Neuropilin-semaphorin III D-mediated chemoresponsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19:995-1005, 1997
32. Kitsukawa T. Shimono A, Kawakami A. et al: Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121:4309-4318. 1995
33. Zhang ZG. Tsang W. Zhang L. et al: Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J Cereb Blood Flow Metab 21:541-549, 2001
34. Chen MK, Strande LF, Beierle EA. et al: Fas-mediated induction of hepatocyte apoptosis in a neuroblastoma and hepatocyte coculture model. J Surg Res 84:82-87, 1999
35. Beierle EA, Strande LF. Geldziler BD, et al: Neuroblastoma and hepatocyte coculture conditioned media alter apoptosis. J Surg Res 90:113-118, 2000
36. Langer I. Vertongen P. Perret J, et al: Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Med Pediatr Oncol 34:386-393, 2000
37. Fakhari M, Pullirsch D, Abraham D, et al: Selective upregulation of vascular endothelialgrowth factor receptors neuropilin-1 and -2 in human neuroblastoma. Cancer 94:258-263, 2002
38. Niimi Y, Mochida S, Matsui A, et al: PKC- and MAPK-independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation. Hepatol Res 21:261-267, 2001
39. Shen BQ, Lee DY, Gerber HP. et al: Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273:29979-29985, 1998
40. Barleon B. Siemeister G. Martiny-Baron G. et al: Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase I (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57:5421-5425. 1997
41. Oh H, Takagi H. Otani A, et al: Selective induction of neurpilin-I by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A 99:383-388, 2002
42. Masood R, Cai J, Zheng T. et al: Vascular endothelial growth factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A 94:979-984, 1997
43. Masood R, Cai J, Zheng T. et al: Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98:1904-1913, 2001
44. Nakagarwara A, Nakamura Y. Ikeda H, et al: High levels of expression and nuclear localization of interleukin-1 β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res 57:4578-4584, 1997
45. Tsurusaki T. Kanda S, Sakai H, et al: Vascular endothelial growth factor-C expression in human prostate carcinoma and its relation ship to lymph node metastasis. Br J Cancer 80:309-313, 1999
46. Gunningham SP, Currie MJ, Han C, et al: The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6:4278-4286, 2000
47. Yonemura Y, Fushida S, Bando E. et al: Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 37:918-923, 2001
48. Kajita T, Ohta Y, Kimura K. et al: The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85:225-260, 2001
49. Miao HQ, Lee P. Lin H. et al: Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 14:2532-2539, 2000
50. Ding H, Wu X, Roncari L. et al: Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer 88:584-592, 2000
51. Handa A, Tokunaga T, Tsuchida T, et al: Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol 17:291-295, 2000
52. Makinen T, Veikkola T. Mustjoki S, et al: Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762-73, 2001
53. Pepper MS, Mandriota SJ: Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp Cell Res 241:414-425. 1998
54. Baek JH, Jang JE, Kang CM. et al: Hypoxia-induced VEGF enhances tumor survivability via a suppression of serum deprivation- induced apoptosis. Oncogene 19:4621-4631. 2000
55. Ryuto M, Ono M, Izumi H, et al: Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220-28238, 1996
56. Feldmann M, Maini RN: Anti TNF-α therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19:163-196, 2001
57. Majka S, McGuire PG. Das A: Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci 43:260-266, 2002
58. Patterson C, Perrella MA. Endege WO, et al: Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-a in cultured human vascular endothelial cells. J Clin Invest 98:490-496, 1996
59. Giraudo E, Primo L, Audero E, et al: Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 273:22128-22135, 1998